LAG-3 (CD223) reduces macrophage and dendritic cell differentiation from monocyte precursors

Immunology

Volumn 114, Issue 3, 2005, Pages 369-374

  Buisson, Sandrine ^a   Triebel, Frédéric ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Cell differentiation; Dendritic cell; MHC Class II; Monocytes

Indexed keywords

CD223 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 4; LYMPHOCYTE ACTIVATION GENE 3 PROTEIN; LYMPHOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; ANTIGENS, CD1; ANTIGENS, CD14; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTERLEUKIN-4; LIGANDS; LYMPHOCYTE ACTIVATION; MACROPHAGES; MONOCYTES; RECOMBINANT PROTEINS;

EID: 14644434385     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2004.02087.x     Document Type: Article

References (26)

1. Chomarat P, Banchereau J, Davoust J, Palucka AK. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nature Immunol 2000; 1:510-14.
2. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994; 179:1109-18.
3. Zhou LJ, Tedder TF. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci USA 1996; 93:2388-592.
4. Triebel F, Jitsukawa S, Baixeras E, Roman-Roman S, Genevée C, Viegas-Pequignot E, Hercend T. LAG-3, a novel lymphocyte activation gene closely related to CD4. J Exp Med 1990; 171:1393-405.
5. Huard B, Gaulard P, Faure F, Hercend T, Triebel F. Cellular expression and tissue distribution of the human LAG-3-encoded protein, a MHC class II ligand. Immunogenetics 1994; 39:213-17.
6. Workman CJ, Rice DS, Dugger K. Phenotypic analysis of the murine CD4-related glycoprotein, CD223 (LAG-3). Eur J Immunol 2002; 32:2255-63.
7. Huard B, Prigent P, Tournier M, Bruniquel D, Triebel F. CD4/major histocompatibility complex class II interaction analyzed with CD4- and lymphocyte activation gene-3 (LAG-3) -Ig fusion proteins. Eur J Immunol 1995; 25:2718-21.
8. Huard B, Tournier M, Hercend T, Triebel F, Faure F. Lymphocyte-activation gene 3/major histocompatibility complex class II interaction modulates the antigenic response of CD4+ T lymphocytes. Eur J Immunol 1994; 24:3216-21.
9. Hannier S, Tournier M, Bismuth G, Triebel F. CD3/TCR complex-associated LAG-3 molecules inhibit CD3/TCR signaling. J Immunol 1998; 161:4058-65.
10. Workman CJ, Vignali DA. The CD4-related molecule, LAG-3 (CD223), regulates the expansion of activated T cells. Eur J Immunol 2003; 33:970-9.
11. Workman CJ, Dugger KJ, Vignali DAA. Molecular analysis of the negative regulatory function of lymphocyte activation gene-3. J Immunol 2002; 169:5392-5.
12. Avice MN, Sarfati M, Triebel F, Delespesse G, Demeure CE. Lymphocyte activation gene-3, a MHC class II ligand expressed on activated T cells, stimulates TNF-alpha and IL-12 production by monocytes and dendritic cells. J Immunol 1999; 162:2748-53.
13. Andreae S, Piras F, Burdin N, Triebel F. Maturation and activation of dendritic cells induced by lymphocyte activation gene-3 (CD223). J Immunol 2002; 168:3874-80.
14. Buisson S, Triebel F. MHC class II engagement by its ligand LAG-3 (CD223) leads to a distinct pattern of chemokine receptor expression by human dendritic cells. Vaccine 2003; 21:862-8.
15. El mir S, Triebel F. A soluble LAG-3 molecule used as a vaccine adjuvant elicits greater humoral and cellular immune responses to both particulate and soluble antigens. J Immunol 2000; 164:5583-9.
16. Cappello P, Triebel F, Iezzi M, et al. LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. Cancer Res 2003; 63:2518-25.
17. Triebel F. LAG-3, a regulator of T-cell and DC responses and its use in therapeutic vaccination. Trends Immunol 2003; 24:619-22.
18. Huard B, Prigent P, Pages F, Bruniquel D, Triebel F. T cell MHC class II molecules downregulate CD4+ T cell clone response following LAG-3 binding. Eur J Immunol 1996; 26:1180-6.
19. Subramanyam M, Wands G, Nabioullin R, Tepper MA. Soluble human lymphocyte activation gene-3 modulates allospecific T cell responses. Int Immunol 1998; 10:679-89.
20. Allavena P, Piemonti L, Longoni D, Bernasconi S, Stoppacciaro A, Ruco L, Mantovani A. IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur J Immunol 1998; 28:359-69.
21. Mariotti S, Teloni R, Iona E, et al. Mycobacterium tuberculosis subverts the differentiation of human monocytes into dendritic cells. Eur J Immunol 2002; 32:3050-8.
22. Sieling PA, Jullien D, Dahlem M, Tedder TF, Rea TH, Modlin RL, Porcelli SA. CD1 expression by dendritic cells in human leprosy lesions: correlation with effective host immunity. J Immunol 1999; 162:1851-8.
23. Coventry B, Heinzel S. CD1a in human cancers: a new role for an old molecule. Trends Immunol 2004; 25:242-8.
24. Demeure C, Wolfers J, Martin-Garcia N, Gaulard P, Triebel F. T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell-cell contacts. Eur J Cancer 2001; 73:1709-18.
25. Andreae S, Buisson S, Triebel F. MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223). Blood 2003; 102:2130-7.
26. Huang CT, Workman CJ, Flies D, et al Role LAG-3 regulatory T cells. Immunity 2004; 21:503-13.